Issues related to domestic healthcare and pricing; Issues related to cell, gene therapies, and radioligand therapies; Issues related to supply chain management, issues related to intellectual property; and issues related to tariffs.
Source-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2025
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- MONUMENT ADVOCACY
- Client
- NOVARTIS
- Filing UUID
- 9288ef6e-2e2f-4058-93fc-481c48cd72f8
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to ongoing trade negotiations; Issues related to US/China relations; Issues related to international intellectual property; Issues related to global health; issues related to supply chain; and issues related to tariffs.
Issues related to US and international tax provisions.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.